BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 31701786)

  • 1. Prognostic Impact of Baseline Hemoglobin Levels on Long-Term Thrombotic and Bleeding Events After Percutaneous Coronary Interventions.
    Nagao K; Watanabe H; Morimoto T; Inada T; Hayashi F; Nakagawa Y; Furukawa Y; Kadota K; Akasaka T; Natsuaki M; Kozuma K; Tanabe K; Morino Y; Shiomi H; Kimura T;
    J Am Heart Assoc; 2019 Nov; 8(22):e013703. PubMed ID: 31701786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ischemic and Bleeding Risk After Percutaneous Coronary Intervention in Patients With Prior Ischemic and Hemorrhagic Stroke.
    Natsuaki M; Morimoto T; Watanabe H; Nakagawa Y; Furukawa Y; Kadota K; Akasaka T; Hanaoka KI; Kozuma K; Tanabe K; Morino Y; Muramatsu T; Kimura T;
    J Am Heart Assoc; 2019 Nov; 8(22):e013356. PubMed ID: 31701821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality Following Cardiovascular and Bleeding Events Occurring Beyond 1 Year After Coronary Stenting: A Secondary Analysis of the Dual Antiplatelet Therapy (DAPT) Study.
    Secemsky EA; Yeh RW; Kereiakes DJ; Cutlip DE; Cohen DJ; Steg PG; Cannon CP; Apruzzese PK; D'Agostino RB; Massaro JM; Mauri L;
    JAMA Cardiol; 2017 May; 2(5):478-487. PubMed ID: 28297015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Baseline Thrombocytopenia on Bleeding and Mortality After Percutaneous Coronary Intervention.
    Ito S; Watanabe H; Morimoto T; Yoshikawa Y; Shiomi H; Shizuta S; Ono K; Yamaji K; Soga Y; Hyodo M; Shirai S; Ando K; Horiuchi H; Kimura T
    Am J Cardiol; 2018 Jun; 121(11):1304-1314. PubMed ID: 29628128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of bleeding academic research consortium (BARC)-defined bleeding complications in ST-segment elevation myocardial infarction: a comparison with the TIMI (Thrombolysis In Myocardial Infarction), GUSTO (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries), and ISTH (International Society on Thrombosis and Haemostasis) bleeding classifications.
    Kikkert WJ; van Geloven N; van der Laan MH; Vis MM; Baan J; Koch KT; Peters RJ; de Winter RJ; Piek JJ; Tijssen JG; Henriques JP
    J Am Coll Cardiol; 2014 May; 63(18):1866-75. PubMed ID: 24657697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Body Weight on Bleeding and Ischemic Events in Patients Undergoing Percutaneous Coronary Intervention - From the CREDO-Kyoto Registry Cohort-2.
    Yamamoto K; Natsuaki M; Yoshikawa Y; Morimoto T; Shiomi H; Watanabe H; Kato T; Saito N; Kadota K; Ando K; Furukawa Y; Tamura T; Sakamoto H; Toyofuku M; Inada T; Inoko M; Suwa S; Onodera T; Ishii K; Kanamori N; Kimura T;
    Circ J; 2020 Sep; 84(10):1734-1745. PubMed ID: 32893236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular Events and Mortality in Patients With Atrial Fibrillation and Anemia (from the Fushimi AF Registry).
    An Y; Ogawa H; Esato M; Ishii M; Iguchi M; Masunaga N; Fujino A; Ide Y; Hamatani Y; Doi K; Ikeda S; Ishigami K; Tsuji H; Wada H; Hasegawa K; Abe M; Lip GYH; Akao M;
    Am J Cardiol; 2020 Nov; 134():74-82. PubMed ID: 32900468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary Intervention.
    Faggioni M; Baber U; Sartori S; Chandrasekhar J; Cohen DJ; Henry TD; Claessen BE; Dangas GD; Gibson CM; Krucoff MW; Vogel B; Moliterno DJ; Sorrentino S; Colombo A; Chieffo A; Kini A; Farhan S; Ariti C; Witzenbichler B; Weisz G; Steg PG; Pocock S; Mehran R
    Circ Cardiovasc Interv; 2019 Apr; 12(4):e007133. PubMed ID: 30998384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemoglobin and Change in Hemoglobin Status Predict Mortality, Cardiovascular Events, and Bleeding in Stable Coronary Artery Disease.
    Kalra PR; Greenlaw N; Ferrari R; Ford I; Tardif JC; Tendera M; Reid CM; Danchin N; Stepinska J; Steg PG; Fox KM;
    Am J Med; 2017 Jun; 130(6):720-730. PubMed ID: 28109968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk: A Patient-Level Stratified Analysis From Four Postapproval Studies.
    Sorrentino S; Claessen BE; Chandiramani R; Guedeney P; Vogel B; Baber U; Rau V; Wang J; Krucoff M; Kozuma K; Ge J; Seth A; Makkar R; Liu Y; Bangalore S; Bhatt DL; Angiolillo DJ; Saito S; Neumann FJ; Hermiller J; Valgimigli M; Mehran R
    Circulation; 2020 Mar; 141(11):891-901. PubMed ID: 31992063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-Analysis of the Prognostic Impact of Anemia in Patients Undergoing Percutaneous Coronary Intervention.
    Kwok CS; Tiong D; Pradhan A; Andreou AY; Nolan J; Bertrand OF; Curzen N; Urban P; Myint PK; Zaman AG; Loke YK; Mamas MA
    Am J Cardiol; 2016 Aug; 118(4):610-20. PubMed ID: 27342283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Baseline Anemia in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: A Prespecified Analysis From the VALIDATE-SWEDEHEART Trial.
    Wester A; Attar R; Mohammad MA; Andell P; Hofmann R; Jensen J; Szummer K; Erlinge D; Koul S
    J Am Heart Assoc; 2019 Aug; 8(16):e012741. PubMed ID: 31387441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ischemic and Bleeding Events After First Major Bleeding Event in Patients Undergoing Coronary Stent Implantation.
    Yamamoto K; Natsuaki M; Morimoto T; Shiomi H; Yoshikawa Y; Tazaki J; Tada T; Watanabe H; Kato E; Toyofuku M; Inada T; Kaneda K; Takeda T; Sakai H; Yamamoto T; Eizawa H; Yamada M; Shinoda E; Mabuchi H; Shirotani M; Matsuda M; Takahashi M; Ishii K; Onodera T; Sakamoto H; Aoyama T; Miki S; Ando K; Kimura T;
    Am J Cardiol; 2022 Jan; 162():13-23. PubMed ID: 34706818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Anemia on Platelet Reactivity and Ischemic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study.
    Giustino G; Kirtane AJ; Baber U; Généreux P; Witzenbichler B; Neumann FJ; Weisz G; Maehara A; Rinaldi MJ; Metzger C; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Brodie BR; Stuckey TD; Gurbel PA; Dangas GD; Francese DP; Ozan O; Mehran R; Stone GW
    Am J Cardiol; 2016 Jun; 117(12):1877-83. PubMed ID: 27131611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of Preprocedural Hemoglobin Level to Outcomes After Percutaneous Coronary Intervention.
    Kim BG; Kim H; Hong SJ; Ahn CM; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y; Kim BK; Lee BK
    Am J Cardiol; 2019 Nov; 124(9):1319-1326. PubMed ID: 31493827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of Baseline Hemoglobin Levels and Adverse Events in Patients With Acute Coronary Syndromes (from the Acute Catheterization and Urgent Intervention Triage strategY and Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction Trials).
    Brener SJ; Mehran R; Dangas GD; Ohman EM; Witzenbichler B; Zhang Y; Parvataneni R; Stone GW
    Am J Cardiol; 2017 Jun; 119(11):1710-1716. PubMed ID: 28388994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of the Academic Research Consortium High Bleeding Risk Criteria in an All-Comers Registry of Percutaneous Coronary Intervention.
    Natsuaki M; Morimoto T; Shiomi H; Yamaji K; Watanabe H; Shizuta S; Kato T; Ando K; Nakagawa Y; Furukawa Y; Tada T; Nagao K; Kadota K; Toyofuku M; Kimura T
    Circ Cardiovasc Interv; 2019 Nov; 12(11):e008307. PubMed ID: 31707804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bleeding Severity After Percutaneous Coronary Intervention.
    Redfors B; Généreux P; Witzenbichler B; Kirtane AJ; McAndrew T; Weisz G; Stuckey TD; Henry TD; Maehara A; Mehran R; Stone GW
    Circ Cardiovasc Interv; 2018 Mar; 11(3):e005542. PubMed ID: 29870382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Renal Dysfunction on the Risks for Ischemic and Bleeding Events in Patients With Atrial Fibrillation Receiving Percutaneous Coronary Intervention.
    Yamamoto K; Shiomi H; Morimoto T; Natsuaki M; Takeji Y; Watanabe H; Yoshikawa Y; Matsumura-Nakano Y; Shizuta S; Tanabe K; Ando K; Kadota K; Morino Y; Kozuma K; Nakagawa Y; Kimura T
    Am J Cardiol; 2020 Feb; 125(3):399-408. PubMed ID: 31771755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of Thrombotic and Bleeding Events After Percutaneous Coronary Intervention: CREDO-Kyoto Thrombotic and Bleeding Risk Scores.
    Natsuaki M; Morimoto T; Yamaji K; Watanabe H; Yoshikawa Y; Shiomi H; Nakagawa Y; Furukawa Y; Kadota K; Ando K; Akasaka T; Hanaoka KI; Kozuma K; Tanabe K; Morino Y; Muramatsu T; Kimura T;
    J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29789335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.